Related references
Note: Only part of the references are listed.Market assessment of tuberculosis diagnostics in South Africa, 2012-2013
W. S. Stevens et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
Defining the Needs for Next Generation Assays for Tuberculosis
Claudia M. Denkinger et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Costs of Novel Tuberculosis Diagnostics-Will Countries Be Able to Afford It?
Andrea Pantoja et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Tuberculosis diagnostics: which target product profiles should be prioritised?
Sandra V. Kik et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling
D. W. Dowdy et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Market Assessment of Tuberculosis Diagnostics in Brazil in 2012
Anete Trajman et al.
PLOS ONE (2014)
Diagnostics for tuberculosis: what test developers want to know
Madhukar Pai
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2013)
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action
William A. Wells et al.
LANCET INFECTIOUS DISEASES (2013)
Optimal Triage Test Characteristics to Improve the Cost-Effectiveness of the Xpert MTB/RIF Assay for TB Diagnosis: A Decision Analysis
Anna H. van't Hoog et al.
PLOS ONE (2013)
Share Paper
